Browsing by Author Chic, Núria
Showing results 1 to 10 of 10
| Issue Date | Title | Author(s) |
|---|---|---|
| 21-May-2019 | Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma | Diaz Mercedes, Sherley; Archilla, Iván; Camps, Jordi; Lacy Fortuny, Antonio Ma. de; Gorostiaga, Iñigo; Momblan, Dulce; Ibarzabal, Ainitze; Maurel Santasusana, Joan; Chic, Núria; Bombí, Josep Antoni; Balaguer Prunés, Francesc; Castells Garangou, Antoni; Aldecoa Ansórregui, Iban; Borràs Andrés, Josep Maria; Cuatrecasas Freixas, Miriam |
| 4-Jan-2021 | Clinical, pathological and PAM50 gene expression features of HER2-low breast cancer | Prat Aparicio, Aleix; Schettini, Francesco; Chic, Núria; Brasó Maristany, Fara; Paré, Laia; Pascual, Tomás; Conte, Benedetta; Martínez Sáez, Olga; Adamo, Barbara; Vidal Losada, Maria Jesús; Fernández Martínez, Aranzazu; González Farré, Blanca; Sanfeliu, Esther; Cejalvo Andújar, Juan Miguel; Perrone, Giuseppe; Sabarese, Giovanna; Zalfa, Francesca; Villagrasa, Patricia; Gavilá, Joaquín; Barrios, Carlos H.; Lluch, Ana; Martín, Miguel; Placido, Sabino De; Barnadas, Esther; Locci, Mariavittoria; Peg, Vicente; Fasan, Roberta |
| 9-Dec-2022 | Cytology Smears: An Enhanced Alternative Method for Colorectal Cancer pN Stage-A Multicentre Study | Diaz Mercedes, Sherley; Archilla, Iván; Lahoz, Sara; Rodrigo Calvo, María Teresa; Lopez Prades, Sandra; Tarragona, Jordi; Landolfi, Stefania; Concha, Ángel; Machado, Isidro; Maurel Santasusana, Joan; Chic, Núria; Castells, Antoni; Balaguer Prunés, Francesc; Camps, Jordi; Cuatrecasas Freixas, Miriam |
| 3-Jan-2022 | Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer | Prat Aparicio, Aleix; Guarneri, Valentina; Pascual, Tomás; Brasó Maristany, Fara; Sanfeliu, Esther; Paré Brunet, Laia; Schettini, Francesco; Martínez, Debora; Jares Gerboles, Pedro; Griguolo, Gaia; Dieci, Maria Vittoria; Cortés, Javier; Llombart Cussac, Antonio; Conte, Benedetta; Marín Aguilera, Mercedes; Chic, Núria; Puig Butillé, Joan Anton; Martínez, Antonio; Galván, Patricia; Tsai, Yi-Hsuan; González Farré, Blanca; Mira, Aurea; Vivancos, Ana; Villagrasa, Patricia; Parker, Joel S.; Conte, Pierfranco; Perou, Charles M. |
| 14-Jul-2020 | ERBB2mRNA expression and response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-positive breast cancer | Griguolo, Gaia; Brasó Maristany, Fara; Gonzalez Farré, Blanca; Pascual, Tomás; Chic, Núria; Saurí, Tamara; Kates, Ronald; Gluz, Oleg; Martínez, Débora; Paré, Laia; Tsvetkova, Vassilena; Pesantez, David; Vidal Losada, Maria Jesús; Adamo, Barbara; Muñoz Mateu, Montserrat; Galván, Patricia; Barberá, Laura; Cuatrecasas Freixas, Miriam; Christgen, Mathias; Kreipe, Hans; Monge Escartín, Inés; Villagrasa, Patricia; Soy Muner, Dolors; Giarratano, Tommaso; Dieci, Maria Vittoria; Conte, Pierfranco; Harbeck, Nadia; Guarneri, Valentina; Prat Aparicio, Aleix |
| 13-May-2020 | Frequency and spectrum of PIK3CA somatic mutations in breast cancer | Martínez Sáez, Olga; Chic, Núria; Pascual, Tomás; Adamo, Barbara; Vidal Losada, Maria Jesús; Gonzalez-Farre, Xavier; Sanfeliu, Esther; Schettini, Francesco; Conte, Benedetta; Brasó Maristany, Fara; Rodriguez, Adela; Martínez, Debora; Galván, Patricia; Rodríguez, Ana Belén; Martínez, Antonio; Muñoz Mateu, Montserrat; Prat Aparicio, Aleix |
| Dec-2022 | HER2DX ERBB2 mRNA expression in advanced HER2- positive breast cancer treated with T-DM1 | Brasó Maristany, Fara; Griguolo, Gaia; Chic, Núria; Pascual, Tomás; Paré Brunet, Laia; Maues, Julia; Galván, Patricia; Dieci, Maria Vittoria; Miglietta, Federica; Giarratano, Tommaso; Martínez Sáez, Olga; Marín Aguilera, Mercedes; Schettini, Francesco; Conte, Benedetta; Angelats, Laura; Vidal Losada, Maria Jesús; Adamo, Barbara; Muñoz, Montse; Sanfeliu, Esther; González Farré, Blanca; Vivancos, Ana; Villagrasa, Patricia; Parker, Joel S.; Perou, Charles M.; Conte, Pierfranco; Prat Aparicio, Aleix; Guarneri, Valentina |
| 19-Mar-2021 | Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer | Griguolo, Gaia; Serna, G.; Pascual, Tomás; Fasani, R.; Guardia, X.; Chic, Núria; Paré, Laia; Pernas, Sònia; Muñoz Mateu, Montserrat; Oliveira, Mafalda; Vidal, M.; Llombart Cussac, Antonio; Cortés, Javier; Galván, Patricia; Bermejo de las Heras, Begoña; Martínez, N.; López, R.; Morales, Serafín; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, E.; Villagrasa, Patricia; Prat Aparicio, Aleix; Nuciforo, Paolo |
| 20-Jan-2020 | Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade | Brasó Maristany, Fara; Griguolo, Gaia; Pascual, Tomás; Paré, Laia; Nuciforo, Paolo; Llombart Cussac, Antonio; Bermejo de las Heras, Begoña; Oliveira, Mafalda; Morales, Serafín; Martínez, Noelia; Vidal Losada, Maria Jesús; Adamo, Barbara; Martínez, Olga; Pernas, Sònia; López, Rafael; Muñoz Mateu, Montserrat; Chic, Núria; Galván, Patricia; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, Eduardo; Gregorio, Sara; Gomis, Roger R.; Villagrasa, Patricia; Cortés, Javier; Ciruelos, Eva; Prat Aparicio, Aleix |
| 7-Jun-2019 | Significant Clinical Activity of Olaparib in a Somatic BRCA1-Mutated Triple-Negative Breast Cancer With Brain Metastasis | Pascual, Tomás; González Farré, Blanca; Teixidó, Cristina; Oleaga Zufiría, Laura; Oses, Gabriela; Ganau, Sergi; Chic, Núria; Riu Viladoms, Gisela; Adamo, Barbara; Galván, Patricia; Vidal Losada, Maria Jesús; Soy Muner, Dolors; Urbano Ispizua, Álvaro; Muñoz Mateu, Montserrat; Prat Aparicio, Aleix |